Register to view:
Pharmacogenomic Investigation of Bruton’s Tyrosine Kinase (BTK) Inhibitor Ibrutinib - Poster
Horizon Discovery drives the application of gene editing and gene modulation within the global life science market - supporting scientists on the path from research to therapy.
Have an account? •